To further distinguish the indicative capacity of USP1 levels in tumor cells versus nontumor cells and to consolidate the aforementioned conclusions, we continued to characterize USP1 levels specifically within tumor cells in clinical tissue specimens. The gene discussed is USP1; the disease is neoplasm.